Mohammed Fakhro et al surveyed 278 patients who underwent lung transplantation. The researchers found that while Bronchiolitis obliterans syndrome (BOS) often limits survival rates following lung transplantation, double-lung transplant recipients showed a better chance of survival despite developing BOS compared to single-lung transplant recipients.
Editor-in-Chief:
Dr Vipin Zamvar, Royal Infirmary of Edinburgh, UK
Proceedings of the World Society of Cardiovascular and Thoracic Surgeons 29th Annual Congress
Edited by Gencho Nachev and Vipin Zamvar
Articles
-
-
Development of a new sternal dehiscence prediction scale for decision making in sternal closure techniques after cardiac surgery
-
The effect of postoperative complications on health-related quality of life and survival 12 years after coronary artery bypass grafting – a prospective cohort study
-
Patient and hospital factors associated with 30-day readmissions after coronary artery bypass graft (CABG) surgery: a systematic review and meta-analysis
-
European registry of type A aortic dissection (ERTAAD) - rationale, design and definition criteria
-
Thoracoscopic plication for a huge thoracic meningocele in a patient with Neurofibromatosis
-
Left ventricular diastolic dysfunction of the cardiac surgery patient; a point of view for the cardiac surgeon and cardio-anesthesiologist
-
Auditory stimulation of opera music induced prolongation of murine cardiac allograft survival and maintained generation of regulatory CD4+CD25+ cells
-
Physiotherapy-supervised mobilization and exercise following cardiac surgery: a national questionnaire survey in Sweden
-
Surveillance of moderate-size aneurysms of the thoracic aorta
Featured article: Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome
Aims and scope
Journal of Cardiothoracic Surgery is an open access journal that encompasses all aspects of research in the field of Cardiology, and Cardiothoracic and Vascular Surgery. The journal publishes original scientific research documenting clinical and experimental advances in cardiac, vascular and thoracic surgery, and related fields.
Topics of interest include surgical techniques, survival rates, surgical complications and their outcomes; along with basic sciences, pediatric conditions, transplantations and clinical trials.
Journal of Cardiothoracic Surgery is of interest to cardiothoracic and vascular surgeons, cardiothoracic anaesthesiologists, cardiologists, chest physicians, and allied health professionals.
Author's quote
“In the last three years, we have been increasingly using BioMed Central journals to present our work. This choice is based on a number of factors, including a streamlined online submission process, rigorous peer-review, open access, and relatively short time from submission to publication. As our experiences while publishing in BioMed Central journals such as Journal of Cardiothoracic Surgery have been excellent, and the benefits of open access to our research are obvious, I intend to continue publishing much of our work through BioMed Central.”
Dr Menelaos Karanikolas, Washington University School of Medicine, USA
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Annual Journal Metrics
-
Speed
78 days to first decision for reviewed manuscripts only
65 days to first decision for all manuscripts
120 days from submission to acceptance
15 days from acceptance to publication
Citation Impact
1.470 - 2-year Impact Factor
1.403 - 5-year Impact Factor
0.880 - Source Normalized Impact per Paper (SNIP)
0.581 - SCImago Journal Rank (SJR)
Usage
784,566 Downloads
249 Altmetric Mentions